Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)
Arrotex Pharmaceuticals Pty Ltd
rizatriptan benzoate
Tablet, orally disintegrating
Excipient Ingredients: acesulfame potassium; crospovidone; ethylcellulose; mannitol; hypromellose; silicon dioxide; sodium stearylfumarate; colloidal anhydrous silica; Flavour
Sublingual
2, 6, 1, 3
(S4) Prescription Only Medicine
for acute treatment of migraine attacks with or without aura.
Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C7' on one side and 'C' on the other side, having a characteristic flavour.; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2015-03-20